Pfizer »

Tourmaline Bio shares owned by Pfizer

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Pfizer from 13F filings

Historical chart of Pfizer investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Pfizer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Pfizer

Quarter filed Position value Share count Share price at filing
2025-09-30 $61M 1.3M 47.83
2025-06-30 $20M 1.3M 15.99
2025-03-31 $19M 1.3M 15.21